Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058678) titled 'Identifying the Utility and Challenges of a Collaborative Genetic Medicine Model through a Questionnaire Survey' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Foundation of Cancer Research, JFCR
Condition:
Condition - Hereditary Cancer Syndrome
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to identify the utility and challenges of a collaborative genetic care model between departments of clinical genetics and primary oncology physicians in the context of hereditary cancer management.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthcare Professionals:1.Aged 18 years or older 2. Medical professionals who are interested in hereditary cancer care (regardless of prior experience or certification)
Patients and Their Family Members:1. Aged 18 years or older 2. Individuals who seek genetic counseling in relation to hereditary cancer syndromes
Key exclusion criteria - Individuals Ineligible to Complete the Questionnaire
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 01 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067095
Disclaimer: Curated by HT Syndication.
